<DOC>
	<DOCNO>NCT00178828</DOCNO>
	<brief_summary>The purpose study understand change brain chemical signal people take antidepressant call sertraline ( Zoloft速 ) bupropion ( Wellbutrin SR , Zyban 速 ) . Spinal fluid use measure chemical level dopamine , serotonin , chemical think involve depression . The study potential help understand treat depression .</brief_summary>
	<brief_title>Dynamic Measures Neurochemistry Mood Disorders</brief_title>
	<detailed_description>The purpose study understand change brain chemical signal people take antidepressant call sertraline ( Zoloft速 ) bupropion ( Wellbutrin SR , Zyban 速 ) . Spinal fluid use measure chemical level dopamine , serotonin , chemical think involve depression . The study potential help understand treat depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>AGE RANGE : 18 50 year . WEIGHT : within 20 % ideal weight , specified 1983 Metropolitan Height Weight Tables . Patients deviate range may review individual basis Investigator . This criterion necessary mechanical risk poor access overweight individual , physiologic risk underweight individual . SEX DISTRIBUTION : men woman ( self partner surgically sterilize , use double barrier method ) . To extent possible , woman CSF sample point menstrual cycle , ideally follicular phase . RACE : HEALTH : healthy , ambulatory depress healthy adult ; must show clear capacity form consent base strong understanding potential risk benefit . Evidence significant hepatic , gastrointestinal , renal , respiratory , endocrine , hematologic , neurologic , psychiatric , cardiovascular system abnormality , history deep venous thrombosis ( DVT ) , thrombophlebitis , coagulopathy . Pregnancy . Patients know suspected history alcohol drug misuse and/or positive urine drug screen . Patients unwilling unable abide requirement study violate prohibition restriction study . Any condition would make patient , opinion Investigator , unsuitable study . Patients take unapproved prior concomitant medication . Patients donate blood within one month study . Patients serious medical illness , history signs/symptoms lumbar spine/disc disease significant laboratory finding . Recent participation study . Patients history migraine consider individually , warn risk headache follow spinal tap . Patients smoke regularly , would experience withdrawal hospitalize 5 day , abstain tobacco entire duration study . Patients present significant suicide risk , e.g . history highly impulsive suicide attempt .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Depression</keyword>
	<keyword>antidepressant</keyword>
	<keyword>SSRI</keyword>
</DOC>